A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Clinical trial NCT07219407 · RECRUITING

Trial details

NCT number: NCT07219407
Sponsor: Rapport Therapeutics Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Focal Epilepsy Epilepsy Refractory Focal Epilepsy Seizure Focal Seizure Focal Onset Seizure

Start date: 2025-12-15
Primary completion: 2028-02-03
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.